HRT for Menopause: What It's Used For and What to Expect

Hormone replacement therapy, commonly called HRT, is probably the most discussed and most misunderstood treatment in menopause care. If you're considering it, you've likely encountered conflicting information: some sources call it a lifeline, others a risk.

Here's what the current evidence actually says.

What is HRT?

HRT replaces the hormones your body produces less of during menopause. The two main hormones involved are:

Estrogen — the primary hormone that declines during menopause. It's responsible for most menopause symptoms and has protective effects on bones, heart, and brain.

Progesterone (or progestogen) — needed alongside estrogen if you still have your uterus. Estrogen alone can cause the uterine lining to thicken, increasing the risk of endometrial cancer. Progesterone counteracts this.

If you've had a hysterectomy, you typically only need estrogen. If you have your uterus, you need both.

What symptoms does HRT treat?

HRT is the most effective treatment available for the core menopause symptoms:

Hot flashes and night sweats — HRT reduces frequency and severity by 75% or more in most women. No other treatment comes close to this level of effectiveness.

Sleep disruption — by reducing night sweats and through direct effects on sleep architecture, HRT often significantly improves sleep quality.

Vaginal dryness and discomfort — estrogen (sometimes applied locally) restores tissue health and moisture. This symptom tends to worsen without treatment and improves reliably with it.

Mood changes — many women report improved mood stability on HRT, particularly if mood symptoms are linked to hormonal fluctuations rather than life circumstances.

Joint pain — estrogen has anti-inflammatory properties. Some women notice a meaningful reduction in joint stiffness and aching.

Bone protection — HRT is one of the most effective ways to prevent the accelerated bone loss that occurs after menopause, reducing fracture risk significantly.

HRT is less clearly effective for brain fog, weight changes, and fatigue, though some women do report improvements in these areas.

Types of HRT

There isn't one standard HRT regimen. Your doctor will recommend a type based on your symptoms, medical history, and preferences.

By hormone combination

• Estrogen-only — for women without a uterus. Simplest regimen with the most favorable risk profile.
• Combined (estrogen + progestogen) — for women with a uterus. The progestogen can be continuous (taken daily) or cyclical (taken for 12-14 days per month).

By delivery method

• Transdermal (patches, gels, sprays) — estrogen absorbed through the skin. This method bypasses the liver and carries a lower risk of blood clots compared to oral forms. Most guidelines now prefer transdermal delivery.
• Oral tablets — swallowed daily. Convenient but passes through the liver, which slightly increases clot risk.
• Vaginal (rings, creams, pessaries) — local estrogen for vaginal and urinary symptoms specifically. Very low dose, minimal systemic absorption. Can be used alone or alongside systemic HRT.

By type of progestogen

• Micronized progesterone (Utrogestan) — body-identical, derived from plants. Generally preferred for its safety profile and fewer side effects.
• Synthetic progestogens — various types, used in many combined HRT formulations. Effective but may carry slightly different risk profiles.

The safety question

This is where the conversation gets complicated. The large-scale Women's Health Initiative (WHI) study in 2002 reported increased risks of breast cancer, heart disease, and stroke with HRT, causing millions of women to stop treatment overnight.

In the years since, re-analysis of the WHI data and numerous additional studies have substantially nuanced that picture:

For women starting HRT under age 60, or within 10 years of menopause:

• The benefits generally outweigh the risks
• There is a reduced risk of heart disease and overall mortality
• Bone fracture risk is significantly reduced
• Quality of life improvements are substantial

Breast cancer risk:

• Estrogen-only HRT does not appear to increase breast cancer risk. The WHI actually found a decreased risk in the estrogen-only group.
• Combined HRT (estrogen + progestogen) is associated with a small increase in breast cancer risk, appearing after about 5 years of use. The increase is roughly equivalent to the risk associated with drinking 2 glasses of wine per day or being obese.
• Using micronized progesterone instead of synthetic progestins appears to carry a lower risk, though long-term data is still accumulating.

Blood clot risk:

• Oral estrogen modestly increases the risk of deep vein thrombosis and pulmonary embolism.
• Transdermal estrogen (patches, gels) does not appear to increase this risk. This is why transdermal delivery is increasingly recommended.

The bottom line on safety: For most women under 60 with menopause symptoms, the benefits of HRT significantly outweigh the risks. The key is individualized assessment with your healthcare provider.

Starting HRT: what to expect

The first few weeks

Most women notice some improvement in hot flashes and sleep within the first 2 to 4 weeks. Full benefit typically takes 3 months. Some women experience breast tenderness, bloating, or mood changes initially. These side effects usually settle within the first 2 to 3 months.

Dosage adjustment

HRT isn't one-size-fits-all. Your doctor will typically start with a low dose and adjust based on your response. This is where symptom tracking becomes particularly valuable: clear data about your symptoms before and after starting (or changing) HRT helps your doctor optimize your dose more quickly.

How long to take it

There's no mandated stop date. The old recommendation to limit HRT to 5 years has been largely abandoned. Current guidelines suggest continuing for as long as the benefits outweigh the risks, with regular review (usually annually).

Some women use HRT for a few years during the most intense symptom phase. Others continue for a decade or more. The decision should be based on your ongoing symptoms, risk factors, and preferences, not an arbitrary timeline.

Stopping HRT

When you decide to stop, gradual tapering is generally recommended over abrupt cessation. This reduces the likelihood of symptoms rebounding. Your doctor can guide you through a tapering schedule.

Who should be cautious about HRT?

HRT may not be appropriate for women with:

• A history of breast cancer
• A history of blood clots (though transdermal estrogen may still be an option)
• Certain types of liver disease
• Undiagnosed vaginal bleeding

Even in these situations, options may exist. The conversation should be with a healthcare provider who's up to date on menopause management.

Preparing for the conversation with your doctor

If you're considering HRT, come prepared:

1. Track your symptoms for at least 2-4 weeks before your appointment. Note frequency, severity, and timing.
2. Know your medical history — particularly any history of blood clots, breast cancer, heart disease, or stroke in yourself or close family members.
3. Ask about delivery methods — if your doctor only offers oral tablets, ask about transdermal options.
4. Ask about the type of progestogen — micronized progesterone is generally preferred if available.
5. Discuss a review timeline — agree on when you'll check in to assess how it's working.

The better your data, the better the conversation. A clear symptom record showing the impact on your daily life is more persuasive than a vague description, and it helps your doctor make more precise recommendations.

---

Ryma helps you build that clear symptom record. Track symptoms via WhatsApp, see how treatments affect your patterns, and share data-driven reports with your doctor.